Human Rights Council resolution 41/10, requested the High Commissioner to organize an full-day intersessional seminar on good practices, key challenges and new developments relevant to access to medicines and vaccines as one of the fundamental elements of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health.

Participants to the virtual consultation must register via Indico (https://indico.un.org/event/35630/). Only those registered will receive the link to join the event, shortly before it starts. Please remember to indicate in the registration form whether you wish to intervene as a speaker during the Questions & Answers sessions.

Objective

The virtual seminar on good practices, key challenges and new developments will explore:

• The key human rights challenges in the context of the COVID-19 pandemic, with a special focus on developing countries and persons living in poverty and in situations of vulnerability;
• Particular challenges of the COVID-19 pandemic for the enjoyment of their human rights by those living in poverty, children and other persons in vulnerable situations, including older persons, persons with disabilities, women, girls, migrants, minorities, LGBTIQ and persons deprived of their liberty.
• The impact of the COVID-19 pandemic and vaccine inequity in terms of growing inequalities, with a particular emphasis on the requirement of the right to the highest attainable standard of physical and mental health to eliminate vaccine inequality;
• Global cooperation and measures that can be adopted in order to improve the universal access to health as a fundamental human right, including access to medicines, medical products, assistive technologies, palliative care and treatments, as well as more advanced technologies;
• Ways and means to increase transnational research and exchange of knowledge in research, development and innovation between developed and developing countries in order to diversify sources of production of medical products and innovation in health, particularly in the context of public health emergencies such as the COVID-19 pandemic.

Format

This virtual seminar will take place on 8 December 2021, in an online platform over two 2-hour sessions (10.00-12.00 and 14.30-16.30 CEST). The programme will focus on two different thematic areas, starting with an overall opening segment, introductions of the theme by the panellists followed by an interactive discussion:

Panel I (10:00 to 12:00 CEST): Human rights challenges in the context of the Covid-19 pandemic, with a special focus on developing countries, particularly their poorest and most vulnerable populations

Panel II (14:30 to 16:30 CEST): Global cooperation and measures to improve the universal access to health as a fundamental human right.

The event is open to Member States, relevant United Nations bodies, agencies, funds and programmes, treaty bodies, special procedure mandate holders, national human rights institutions, civil society, the private sector and other relevant stakeholders.

Information regarding participation, including the submission of statements for the interactive discussion, and technical guidance as well as the online platform hosting the event, is available separately. Simultaneous interpretation will be available in six languages (Arabic, Chinese, English, French, Russian and Spanish).

Background documents

• Programme
• Concept note
• Guidance for speakers' list
• Human Rights Council resolution 41/10 of 19 July 2019 entitled “Access to medicines and vaccines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health”
• Human Rights Council resolution 46/14 of 29 March 2021 entitled “Ensuring equitable, affordable, timely and universal access for all countries to vaccines in response to the coronavirus disease (COVID-19) pandemic”
• Impact of the coronavirus disease (COVID-19) pandemic on the enjoyment of human rights around the world, including good practices and areas of concern, Report of the United Nations High Commissioner for Human Rights (A/HRC/46/19, March 2021)
• Central role of the State in responding to pandemics and other health emergencies, and the socioeconomic consequences thereof, in advancing sustainable development and the realization of all human rights, Report of the Office of the United Nations High Commissioner for Human Rights (A/HRC/47/23, May 2021)
• WHO Road Map for Access to Medicines, Vaccines and other Related Health Products 2019–2023
• General Assembly resolution 73/3 of 10 October 2018 entitled ‘Political declaration of the high-level meeting of the General Assembly on the fight against tuberculosis’
• General Assembly resolution 73/2 of 10 October 2018 entitled ‘Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases’
• General Assembly resolution 71/3 of 5 October 2016 entitled ‘Political declaration of the high-level meeting of the General Assembly on antimicrobial resistance’
• United Nations Secretary-General’s High-level Panel on Access to Medicines (web page) and the Panel’s report on promoting innovation and access to health technologies (September 2016)
• Human Rights Council resolution 32/15 of 1 July 2016 entitled “Access to medicines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health”
• General Assembly resolution 70/1 of 25 September 2015 entitled “Transforming our world: the 2030 Agenda for Sustainable Development”
• Report of the 2015 Social Forum on Access to Medicines (A/HRC/29/44)
• Report of the Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health, Anand Grover, on access to medicines (A/HRC/23/42), 1 May 2013
• Report of the Special Rapporteur on the right to everyone to the enjoyment of the highest attainable standard of physical and mental health, Paul Hunt, on Human Rights Guidelines for Pharmaceutical Companies in relation to Access to Medicines (A/63/263), 11 August 2008
• Committee on Economic, Social and Cultural Rights, General comments No. 14 (2000) and No. 17 (2006)

Contributors

High Level Opening

• Ms. Michelle Bachelet, United Nations High Commissioner for Human Rights, Office of the High Commissioner for Human Rights (OHCHR) [video statement] and [written statement]
• Dr. Marcelo Queiroga, Minister of Health, Brazil [video statement] and [written statement]

PANEL I. Human rights challenges in the context of the Covid-19 pandemic, with a special focus on developing countries, particularly their poorest and most vulnerable populations

• Mr. Michel Kazatchkine, Member of the Independent Panel for Pandemic Preparedness and Response (IPPR) and Senior Fellow, Global Health Center, Graduate Institute of International and Development Studies, Switzerland [written statement]
• Ms. Nizia Trindade, President of FIOCRUZ [video statement] and [written statement]
• Mr. Deprose Muchena, Director for Eastern and Southern Africa, Amnesty International
• Ms. Jane Barratt, Secretary General, International Federation on Ageing
• Dr. Adeeba Kamarulzaman, Dean of the Faculty of Medicine, University of Malaya, Malaysia, and Member of the WHO Science Council

INTERACTIVE DIALOGUE PANEL I

• Bolivia [written-statement]
• EU [video intervention] and [written statement]
• Iran [written statement: 1-2]
• Indonesia [written statement]
• UN Diplomatic Committee (UNDC) [written statement]

PANEL II. Global cooperation and measures to improve the universal access to health as a fundamental human right

• Mr. Anand Grover, former Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health
• Hon. Justice Zione Ntaba, Judge of the High Court of Malawi
• Mr. Anthony Taubman, Director, Intellectual Property Division, World Trade Organization
• Dr. Clive Ondari, Director of Health Products Policy and Standards department, World Health Organization
• Ms. Magdalena Babinska, COVID-19 Project Manager, Medicines Patent Pool
• Mr. Obijiofor Aginam, Adjunct Research Professor of Law, Carleton University, Canada
• Mr. Mohamed Abdel-Moneim, Chair of the Committee on Economic, Social and Cultural Rights

INTERACTIVE DIALOGUE PANEL II

• Barbados [video statement] and [written statement]
• Cuba [written statement]
• Iran [written statement: 1-2]
• Mexico [written statement]
• Peru [video statement] and [written statement]
• Associazione Papa Giovanni XXIII (APG23)
• Human Rights Watch

Conclusions and closing

• Ms. Peggy Hicks, Director, Thematic Engagement, Special Procedures and Right to Development, OHCHR

Webcasts:

• 1st Meeting, Intersessional Seminar on Access to Medicines & Vaccines - Human Rights Council | UN Web TV
• 2nd Meeting, Intersessional Seminar on Access to Medicines & Vaccines - Human Rights Council | UN Web TV